Sustained HBeAg and HBsAg loss after longterm follow-up of HBeAg positive patients treated with peginterferon alpha-2B
dc.contributor.author | Buster, Erik H. | |
dc.contributor.author | Flink, Hajo J. | |
dc.contributor.author | Cakaloglu, Yilmaz | |
dc.contributor.author | Simon, Christopher | |
dc.contributor.author | Trojan, Joerg | |
dc.contributor.author | Tabak, Fehmi | |
dc.contributor.author | So, Thomas M. | |
dc.contributor.author | Feinman, Victor S. | |
dc.contributor.author | Mach, Tomasz | |
dc.contributor.author | Akarca, Ulus | |
dc.contributor.author | Tielemans, Wanda C. | |
dc.contributor.author | van Vuuren, Hanneke J. | |
dc.contributor.author | Hansen, Bettina E. | |
dc.contributor.author | Janssen, Harry L. | |
dc.date.accessioned | 2019-10-27T20:01:20Z | |
dc.date.available | 2019-10-27T20:01:20Z | |
dc.date.issued | 2007 | |
dc.department | Ege Üniversitesi | en_US |
dc.description | 58th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases -- NOV 02-06, 2007 -- Boston, MA | en_US |
dc.description.sponsorship | Amer Assoc Study Liver Dis | en_US |
dc.identifier.endpage | 667A | en_US |
dc.identifier.issn | 0270-9139 | |
dc.identifier.issn | 1527-3350 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.startpage | 667A | en_US |
dc.identifier.uri | https://hdl.handle.net/11454/41251 | |
dc.identifier.volume | 46 | en_US |
dc.identifier.wos | WOS:000249910401228 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.ispartof | Hepatology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Sustained HBeAg and HBsAg loss after longterm follow-up of HBeAg positive patients treated with peginterferon alpha-2B | en_US |
dc.type | Conference Object | en_US |